Navigation Links
MINRAD International, Inc. Announces 2007 Financial Results
Date:3/31/2008

2,622 -

Commitments and contingencies - -

Stockholders' equity:

Series A convertible preferred stock - -

Common stock 487 470

Additional paid in capital 80,869 76,513

Accumulated deficit (62,279) (43,481)

Total stockholders' equity 19,077 33,502

$ 41,995 $ 35,729

MINRAD INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

Years Ended

December December

31, 31,

2007 2006

Revenue $12,952 $16,341

Cost of goods sold 13,518 10,754

Gross profit (566) 5,587

Operating expenses:

Sales and marketing 8,407 5,074

Research and development 5,404 2,916

Finance and administrative 4,375 4,636

Total operating expenses 18,186 12,626

Operating loss (18,752) (7,039)

Non-operating income (expenses):

Interest expense (2) (155)

Interest income 162 642

Warrant inducement
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
5. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
6. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
7. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
8. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
9. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
10. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
11. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
... composed of polymer layers and nanoparticles may ...without harming the rest of the body, according to...m could be robust and flexible enough to deliver a...te student, chemical engineering. "The drugs are p...
...ickly becoming the "it" nutrient with health benef...heart disease and now diabetes. , A recent revi...iversity Chicago Marcella Niehoff School of Nursin...nosed. These findings appeared in the latest issu...
...rsity of Arizona are developing a set of standardi...ith Down syndrome. , The condition, which occurs...ths, is signaled by the presence of an extra 21st ...early onset of Alzheimer,s dementia. New research ...
... be paid after hospital discharge, , , MON...the veterans treated in Veterans Affairs hospitals...ter risk of suicide than non-depressed veterans, ...esearchers wondered? , Their five-year study of v...
...l Year 2008 Earnings Conference Call , Thursday, F...ZER, Pa., Jan. 12 Cephalon, Inc . (Nasdaq: CEP...onference call covering fourth quarter and full ye... will be distributed by PRNewswire , 4:50 p.m. EST...
...a worthy cause at Access Hollywood,s 3rd Annual "S...Lollipop Theater Network. , , LOS ANGELES, Jan. 1..., once again donated $100,000 to two important cha...onsecutive beauty sponsorship of the lounge, which...
Other Medicine News:Health News:Tiny capsules deliver 2Health News:Vitamin D is the 'it' nutrient of the moment 2Health News:Standardized test battery to aid those with Down syndrome 2Health News:Standardized test battery to aid those with Down syndrome 3Health News:Standardized test battery to aid those with Down syndrome 4Health News:Standardized test battery to aid those with Down syndrome 5Health News:Standardized test battery to aid those with Down syndrome 6Health News:With Depression, Vets Face Higher Suicide Risk 2Health News:With Depression, Vets Face Higher Suicide Risk 3Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 2Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 3
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...s,Inc. (Amex: IMM ) is pleased to announce today ...h as a strategic advisor. General Clark will,provi...pany develops its,drug programs targeting various ...tion and treatment. General Clark is one of the c...ers and a respected international voice in public ...
...ry biliary cirrhosis patient,has the biomarker of ...nic,researchers have found that first-degree relat...s with primary biliary cirrhosis (PBC) are,more li... blood. Armed with,this new information, physician...f PBC patients with a simple blood test, enabling ...
Other Medicine Technology:General Wesley Clark Joins Immtech as Consulting Strategic Advisor 2General Wesley Clark Joins Immtech as Consulting Strategic Advisor 3New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2
DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
DNA Engine Thermal Cycler Chassis
MBS Satellite Thermal Cycler 0.5ml
MBS Satellite Thermal Cycler 0.2ml
Medicine Products: